Evaluation of dose-efficacy of sorafenib and effect of transarterial chemoembolization in hepatocellular carcinoma patients: a retrospective study

BACKGROUND: Transarterial chemoembolization (TACE) and sorafenib are the therapeutic standard for intermediate and advanced stage hepatocellular carcinoma (HCC) patients respectively. High costs with adverse events (AE) of sorafenib might limit sorafenib dosage, further affecting therapeutic respons...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Gastroenterol
Main Authors: Hsiao, Wang-De, Peng, Cheng-Yuan, Chuang, Po-Heng, Lai, Hsueh-Chou, Cheng, Ken-Sheng, Chou, Jen-Wei, Chen, Yang-Yuan, Yu, Cheng-Ju, Feng, Chun-Lung, Su, Wen-Pang, Chen, Sheng-Hung, Kao, Jung-Ta
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4847248/
https://ncbi.nlm.nih.gov/pubmed/27117280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-016-0464-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados